Hospital de Mataro

Mataró, Barcelona 08304

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Type 2, First Line Non-Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer — Stopped early
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed